Observations: A monoclonal population of T cells was found in blood samples from 13 (34%) of 38 consecutive patients with a definite diagnosis of systemic sclerosis who were prospectively examined by T-cell receptor ␥ gene rearrangement using polymerase chain reaction analysis and denaturating gradient gel electrophoresis. In the healthy control group, the same type of examination revealed a monoclonal population of T cells in the blood samples from only 3 healthy subjects (4%)(odds ratio, 12.28; 95% confidence interval, 2.76-54.64; P=.001).
Patients who had a circulating clonal population of T cells were older than those who did not (67 years vs 48 years; P =.04). There was a marked relationship between systemic sclerosis subtypes and the presence of a circulating clonal population of T cells. Twelve (43%) of 28 patients with limited cutaneous sclerosis exhibited a circulating clonal population of T cells, whereas only 1 (10%) of the 10 patients with diffuse cutanous sclerosis had evidence of T-cell clonality (PϽ.01).
Conclusions:
Clonally expanded T cells were more commonly detected in patients with limited cutaneous sclerosis than in those with diffuse cutaneous sclerosis, which is also in accordance with a possible role of clonal T cells in patients with limited cutaneous sclerosis.
Arch Dermatol. 2005; 141:88-89 I N A PROSPECTIVE STUDY, FRENCH et al 1 found that clonal T cells are frequently detected in peripheral blood samples from patients with systemic sclerosis (SSc). In their series, expanded clonal T cells were found in 6 (46%) of 13 peripheral blood samples from patients with SSc, whereas no clonal T cells were found in the control group. 1 The authors suggested that clonal T cells may play a critical role in the pathogenesis of SSc. 1 These data prompted us to conduct a prospective study (1) to evaluate the prevalence of a T-cell clonal population in peripheral blood samples from patients with SSc and (2) to determine a possible relationship between both clinical and biological parameters of patients with SSc and the presence of a T-cell clonal population in peripheral blood samples.
METHODS
Blood samples were obtained from all patients, and peripheral blood mononuclear cells were immediately isolated from whole blood using the Ficoll-Hypaque technique. 1 Analysis of T-cell receptor ␥ gene rearrangement using polymerase chain reaction and denaturating gradient gel electrophoresis (TCR-␥ PCR DGGE) was performed as previously described. Thirty-eight consecutive patients with a definite diagnosis of SSc were included in the study. The criteria for the diagnosis of SSc were based on the American College of Rheumatology criteria. 3 All patients were seen at the University of Rouen Medical Center, Rouen, France, between 2001 and 2002. There were 6 men and 32 women, with a median age of 54 years (age range, 26-87 years); the median duration of the disease, considered to have existed from the onset of the Raynaud phenomenon, was 55 months (range, 8-432 months). Patients were classified according to the criteria of Leroy et al 3 : 10 patients (26%) had diffuse cutaneous SSc (dcSSc) and 28 (74%) had limited cutaneous SSc (lcSSc).
The findings of TCR-␥ PCR DGGE of the blood samples from patients with SSc were compared with those from 76 age-and sexmatched healthy subjects (12 men and 64 women; median age, 57 years; age range, 29-89 years). For each patient, we attempted to select 2 same-sex control subjects whose age was within 5 years of the patient's age. None of the patients with SSc or the control subjects had a history of other connective tissue disorders or hematologic diseases (eg, lymphoma, cutaneous T-cell lymphoma, or T-cell leukemias).
Statistical analyses were performed using commercially available software (Version 8
as significant at PϽ.05. For comparisons of patients with SSc and control subjects, conditional logistic regression was also performed, and matched odds ratios (ORs) with their 95% confidence intervals (CIs) were calculated.
RESULTS

PREVALENCE OF BLOOD T-CELL CLONALITY
Using TCR-␥ PCR DGGE, a monoclonal population of T cells was detected in blood samples from 13 (34%) of 38 consecutive patients with SSc. In the healthy control group, TCR-␥ PCR DGGE revealed a monoclonal population of T cells in blood samples from only 3 subjects (4%) (OR, 12.28; 95% CI, 2.76-54.64; P = .001).
FACTORS ASSOCIATED WITH A T-CELL CLONAL POPULATION
Patients with SSc who had a circulating clonal population of T cells were older than those who did not (67 years vs 48 years; P=.04). Among female patients, a history of pregnancy was similar in patients with and without clonal T cells (71% vs 62%; PϾ.99).
The median duration of SSc was significantly longer in patients with a T-cell clonality than in those without (78 months vs 36 months; P= .01). Moreover, we were able to demonstrate a marked relationship between SSc subtypes and the presence of a circulating clonal population of T cells: 12 (43%) of the 28 patients with lcSSc had a circulating clonal population of T cells, whereas only 1 (10%) of the 10 patients with dcSSc had evidence of T-cell clonality (PϽ.01).
The prevalence of the following systemic manifestations related to SSc was similar in patients with and without a circulating clonal population of T cells: (1) pitting scars (54% vs 56%; PϾ.99); (2) esophageal involvement characterized by motor disturbances on esophageal manometry (91% vs 72%; PϾ.99); (3) interstitial lung disease defined on computed tomograms by bilateral shadowing associated with pulmonary function test abnormalities manifested by restrictive changes (ie, vital capacity, Ͻ80%) and a diffusing capacity for carbon monoxide of less than 70% predicted (23% vs 12%; P=.39); (4) articular dysfunction (46% vs 40%; P=.74); and (5) renal crisis (0% vs 8%; P=.53). We also failed to find a significant difference in the degree of SSc severity 4 
between patients with and without a circulating clonal population of T cells (4 vs 4; P=.20).
Finally, no differences were found in the following laboratory values between patients with SSc who had a circulating clonal population of T cells and those who did not: erythrocyte sedimentation rate, 18 mm/h vs 12 mm/h (P = .35); C-reactive protein, 3 mg/L vs 3 mg/L; (P=.35); hemoglobin, 12.9 g/dL vs 13.0 g/dL (8.0 mmol/L vs 8.1 mmol/L) (P=.71); serum urea nitrogen, 15.4 mg/dL vs 14.0 mg/dL (5.5 mmol/L vs 5.0 mmol/L; P = .03). The frequency of anti-Scl-70 antibodies (8% vs 24%; P =.38) and anticentromere antibodies (46% vs 36%; P=.54) was also similar in the 2 groups, respectively.
COMMENT
Although clonality of T cells is more commonly encountered in diseases involving T-cell lineage (eg, cutaneous T-cell lymphoma and T-cell leukemias), it may be associated with other conditions, including autoimmune disorders such as rheumatoid arthritis, as well. 5 Our study also demonstrated a marked frequency (34%) of clonally expanded T cells in the peripheral blood samples from patients with SSc compared with the general population. Our findings therefore confirm the data of previous authors who have observed clonal T-cell populations in samples of blood 1 and numerous organs (eg, skin and lungs) of 20% to 56% patients with SSc. [6] [7] [8] Previous authors 1, [6] [7] [8] have also suggested that clonal populations of T cells may have a role in the pathogenesis of SSc. In essence, in a recent series, French et al 1 showed that patients with SSc who have detectable expanded clonal T-cell populationsinsamplesofperipheralbloodappearmorelikely to respond to extracorporeal photophoresis. They postulated that these findings reinforce the theory that clonal T cells may be involved in the pathogenesis of SSc, as extracorporeal photophoresis has been reported to be an efficacious therapy in patients with other T-cell disorders, such as the Sézary syndrome (ie, the leukemic form of cutaneous T-cell lymphoma). In our population, no patient underwent photophoresis. In the present study, the demonstration that clonally expanded T cells were more commonly detected in patients with lcSSc than in those with dcSSc is also in accordance with a possible role of clonal T cells in patients with lcSSc. To date, however, the pathogenic properties of these clonal T cells have not been clearly shown in SSc. Finally, it is of interest to note that the presence of clonally expanded T cells in the peripheral blood samples in our study could not be considered as a predictive factor of organ involvement severity in patients with SSc. 
